 | | PRD_000893 | | Name: | METHYL (2S)-1-[(2R,5S,8S,12S,13S)-2,13-DIBENZYL-12-HYDROXY-3,5-DIMETHYL-15-(3-[METHYL(METHYLSULFONYL)AMINO]-5-{[(1R)-1-PHENYLETHYL]CARBAMOYL}PHENYL)-8-(2-METHYLPROPYL)-4,7,10,15-TETRAOXO-3,6,9,14-TETRAAZAPENTADECAN-1-OYL]PYRROLIDINE-2-CARBOXYLATE | | Formula: | C54 H69 N7 O11 S | | Definition date: | 2012-12-12 | | Last modified: | 2013-06-03 |
|
 | | PRD_000898 | | Name: | METHYL (2S)-1-[(2R,5S,8S,12S,13S,16S,19S,22S)-16-(3-AMINO-3-OXOPROPYL)-2,13-DIBENZYL-12,22-DIHYDROXY-3,5,17-TRIMETHYL-8-(2-METHYLPROPYL)-4,7,10,15,18,21-HEXAOXO-19-(PROPAN-2-YL)-3,6,9,14,17,20-HEXAAZATRICOSAN-1-OYL]PYRROLIDINE-2-CARBOXYLATE (NON-PREFERRED NAME) | | Formula: | C50 H74 N8 O12 | | Definition date: | 2013-01-16 | | Last modified: | 2013-06-03 |
|
 | | PRD_000899 | | Name: | METHYL (2S)-1-[(2R,5S,8S,12S,13S)-2,13-DIBENZYL-12-HYDROXY-3,5-DIMETHYL-8-(2-METHYLPROPYL)-15-(3-[(METHYLSULFONYL)AMINO]-5-{[(1R)-1-PHENYLETHYL]CARBAMOYL}PHENYL)-4,7,10,15-TETRAOXO-3,6,9,14-TETRAAZAPENTADECAN-1-OYL]PYRROLIDINE-2-CARBOXYLATE | | Formula: | C53 H67 N7 O11 S | | Definition date: | 2013-01-16 | | Last modified: | 2013-06-03 |
|
 | | PRD_000910 | | Name: | B4Z inhibitor | | Formula: | C24 H44 N6 O6 | | Definition date: | 2012-12-12 | | Last modified: | 2013-06-03 |
|
 | | PRD_000911 | | Name: | C4Z inhibitor | | Formula: | C27 H42 N6 O6 | | Definition date: | 2012-12-12 | | Last modified: | 2013-06-03 |
|
 | | PRD_000912 | | Name: | C6Z inhibitor | | Formula: | C34 H54 N8 O10 | | Definition date: | 2012-12-12 | | Last modified: | 2013-06-03 |
|
 | | PRD_000922 | | Name: | PL-42 | | Formula: | C39 H63 N9 O14 P S | | Definition date: | 2013-04-03 | | Last modified: | 2013-06-03 |
|
 | | PRD_000940 | | Name: | D-PHE-PRO-D-ARG-D-THR DERIVED DIRECT THROMBIN INHIBITOR | | Formula: | C24 H39 N8 O5 | | Definition date: | 2013-04-17 | | Last modified: | 2013-06-03 |
|
 | | PRD_000184 | | Name: | Microcin J25 | | Formula: | C101 H140 N23 O27 | | Definition date: | 2012-12-12 | | Last modified: | 2013-06-03 |
|
 | | PRD_000966 | | Name: | [(5S)-5-[[(2S)-6-azaniumyl-2-[[(2S)-6-azaniumyl-2-[2-[[(2S)-2-[[(2S)-2-[[(2S,5S,8S,11S,20S)-20-[[(2S)-2-[[(2S,3R)-2-[[(2S,3S)-2-azanyl-3-methyl-pentanoyl]amino]-3-oxidanyl-butanoyl]amino]-3-phenyl-propanoyl]amino]-2-(2-hydroxy-2-oxoethyl)-11,20-dimethyl-5,8-bis(2-methylpropyl)-3,6,9,21-tetrakis(oxidanylidene)-1,4,7,10-tetrazacyclohenicos-11-yl]carbonylamino]-3-(4-hydroxyphenyl)propanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]ethanoylamino]hexanoyl]amino]hexanoyl]amino]-6-oxidanyl-6-oxidanylidene-hexyl]azanium | | Formula: | C87 H140 N17 O20 | | Definition date: | 2012-12-12 | | Last modified: | 2013-06-03 |
|
 | | PRD_000976 | | Name: | N-acetyl-L-valyl-L-alpha-glutamyl-N-[(2S)-1-carboxy-3-oxopropan-2-yl]-L-isoleucinamide | | Formula: | C22 H36 N4 O9 | | Definition date: | 2012-12-12 | | Last modified: | 2013-06-03 |
|
 | | PRD_000977 | | Name: | 1-acetyl-L-prolyl-L-threonyl-N-[(2R,3S)-4-chloro-3-hydroxy-1-(4-hydroxyphenyl)butan-2-yl]-L-serinamide | | Formula: | C24 H35 Cl N4 O8 | | Definition date: | 2012-12-12 | | Last modified: | 2013-06-03 |
|
 | | PRD_000989 | | Name: | ISOAMYLPHOSPHONYL-GLY-PRO-ALA | | Formula: | C15 H28 N3 O6 P | | Definition date: | 2012-12-12 | | Last modified: | 2013-06-03 |
|
 | | PRD_000997 | | Name: | JTH-NB72-39 | | Formula: | C42 H74 N14 O9 S | | Definition date: | 2012-12-12 | | Last modified: | 2013-06-03 |
|
 | | PRD_000999 | | Name: | ALPHA-BETA-FOLDAMER 2C | | Formula: | C110 H166 N28 O28 | | Definition date: | 2012-12-12 | | Last modified: | 2013-06-03 |
|
 | | PRD_001002 | | Name: | [Aba3,7,12,16]BTD-2 | | Formula: | C82 H156 N36 O18 S2 | | Definition date: | 2013-02-27 | | Last modified: | 2013-06-03 |
|
 | | PRD_001006 | | Name: | [Aba5,7,12,14]BTD-2 | | Formula: | C82 H156 N36 O18 S2 | | Definition date: | 2013-02-27 | | Last modified: | 2013-06-03 |
|
 | | PRD_001009 | | Name: | [Aba3,5,7,12,14,16]BTD-2 | | Formula: | C84 H162 N36 O18 | | Definition date: | 2013-02-27 | | Last modified: | 2013-06-03 |
|
 | | PRD_001013 | | Name: | Peptide Inhibitor (ACE)ADVAD-CHO | | Formula: | C21 H33 N5 O10 | | Definition date: | 2012-12-12 | | Last modified: | 2013-06-03 |
|
 | | PRD_001014 | | Name: | APO-monomer | | Formula: | C115 H198 N39 O24 | | Definition date: | 2013-04-17 | | Last modified: | 2013-06-03 |
|
 | | PRD_001020 | | Name: | GDC0152 | | Formula: | C25 H34 N6 O3 S | | Definition date: | 2012-12-12 | | Last modified: | 2013-06-03 |
|
 | | PRD_001030 | | Name: | ACE-PHE-GLU-LYS-ALA chloromethylketone INHIBITOR | | Formula: | C26 H41 Cl N5 O7 | | Definition date: | 2012-12-12 | | Last modified: | 2013-06-03 |
|
 | | PRD_001045 | | Name: | TMC-95A mimic ligand yCP:4a chain P | | Formula: | C43 H47 N5 O9 | | Definition date: | 2013-05-01 | | Last modified: | 2013-06-03 |
|
 | | PRD_001048 | | Name: | N-acetyl-L-valyl-L-alpha-aspartyl-L-valyl-N-[(2R)-1-carboxy-3-oxopropan-2-yl]-L-alaninamide | | Formula: | C23 H37 N5 O10 | | Definition date: | 2012-12-12 | | Last modified: | 2013-06-03 |
|
 | | PRD_001052 | | Name: | N-acetyl-L-alpha-aspartyl-L-valyl-N-[(2S)-1-carboxy-3-oxopropan-2-yl]-L-alaninamide | | Formula: | C18 H28 N4 O9 | | Definition date: | 2012-12-12 | | Last modified: | 2013-06-03 |
|
